Nanocrystals for controlled delivery: state of the art and approved drug products

References

• Ranjan D, Subashini R, Murugananthan G. Pharmaceutical nanocrystals. In: Anand K, Saravanan M, Chandrasekaran B, Kanchi S, Panchu S, Chen, Q, editors. Handbook on nanobiomaterials for therapeutics and diagnostic applications. 1st ed. Elsevier; 2021. p. 409–420. B978-0-12-821013-0.00019-2.
   Google Scholar
• DJF, U.S. Food and Drug Administration. Considering whether an FDA-regulated product involves the application of nanotechnology. Docket Number: FDA-2010-D-0530; 2014 June. [cited 2022 May 9]. Available from: http://www.fda.gov/RegulatoryInformation/Guidances/ucm257698.htm
   Google Scholar
• Boverhof DR, Bramante CM, Butala JH, et al. Comparative assessment of nanomaterial definitions and safety evaluation considerations. Regul Toxicol Pharmacol. 2015;73(1):137–150.
   PubMed Web of Science ®Google Scholar
• Junghanns J-UA, RHJIjon M. Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed. 2008;3(3):295.
   PubMed Web of Science ®Google Scholar
• Wong J, Brugger A, Khare A, et al. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv Drug Deliv Rev. 2008;60(8):939–954.
   PubMed Web of Science ®Google Scholar
• Mou D, Chen H, Wan J, et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm. 2011;413(1–2):237–244.
   PubMedGoogle Scholar
• Karakucuk A, Teksin ZS, Eroglu H, et al. Evaluation of improved oral bioavailability of ritonavir nanosuspension. Eur J Pharm Sci. 2019;131:153–158.
   PubMed Web of Science ®Google Scholar
• Gulsun T, Borna SE, Vural I, et al. Preparation and characterization of furosemide nanosuspensions. J Drug Deliv Sci Technol. 2018;45:93–100.
   Web of Science ®Google Scholar
• Rahim H, Sadiq A, Khan S, et al. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition. Int J Nanomed. 2019;14:6287.
   PubMed Web of Science ®Google Scholar
• Chavan DU, Marques SM, Bhide PJ, et al. Rapidly dissolving felodipine nanoparticle strips-formulation using design of experiment and characterisation. J Drug Deliv Sci Technol. 2020;60:102053.
   Web of Science ®Google Scholar
• Sahu BP, MKJAn D. Nanosuspension for enhancement of oral bioavailability of felodipine. Appl Nanosci. 2014;4(2):189–197.
   Web of Science ®Google Scholar
• Qiu L, Zhao X, Zu Y, et al. Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability. Artif Cells Nanomed Biotechnol. 2019;47(1):609–620.
   Web of Science ®Google Scholar
• Xiong S, Liu W, Li D, et al. Oral delivery of puerarin nanocrystals to improve brain accumulation and anti-parkinsonian efficacy. Mol Pharm. 2019;16(4):1444–1455.
   PubMedGoogle Scholar
• Wang GD, Mallet FP, Ricard F, et al. Pharmaceutical nanocrystals. Curr Opin Chem Eng. 2012;1(2):102–107.
   Web of Science ®Google Scholar
• Fujii H, Watano SJC, Bulletin P. Development of universal formulation with superior re-dispersion using nanocrystal approach with simultaneous identification of API physicochemical properties. Chem Pharm Bull. 2019;67(10):1050–1060.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wu L, Chan H-K, et al. Formation, characterization, and fate of inhaled drug nanoparticles. Adv Drug Deliv Rev. 2011;63(6):441–455.
   PubMed Web of Science ®Google Scholar
• JPJIjop M. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm. 2013;453(1):142–156.
   PubMedGoogle Scholar
• Malamatari M, Taylor KM, Malamataris S, et al. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discovery. 2018;23(3):534–547.
   Google Scholar
• Liversidge GG, Conzentino PJIJOP. Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats. Int J Pharm. 1995;125(2):309–313.
   Google Scholar
• Liversidge GG, Cundy KC, Bishop JF, et al. Surface modified drug nanoparticles. US5145684. 1992. [cited 2022 May 9].
   Google Scholar
• Müller RH, KJIjop P. Nanosuspensions for the formulation of poorly soluble drugs: i. Preparation by a size-reduction technique. Int J Pharm. 1998;160(2):229–237.
   Web of Science ®Google Scholar
• Chen MJ, Hui H-W, Lee T, et al. Nanosuspension of a poorly soluble drug via microfluidization process. Google Patents; 2015.
   Google Scholar
• Patravale V, Date AA, RJJop K, et al. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56(7):827–840.
   PubMed Web of Science ®Google Scholar
• W-t C, Li Y, Y-w G. Injected nanocrystals for targeted drug delivery. Acta Pharm Sin B. 2016;6(2):106–113.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Du J, Wang L, et al. Nanocrystals technology for improving bioavailability of poorly soluble drugs: a mini-review. J Nanosci Nanotechnol. 2017;17(1):18–28.
   PubMed Web of Science ®Google Scholar
• Rabinow B, Kipp J, Papadopoulos P, et al. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int J Pharm. 2007;339(1–2):251–260.
   PubMedGoogle Scholar
• Wang D, Wang Y, Zhao G, et al. Improving systemic circulation of paclitaxel nanocrystals by surface hybridization of DSPE-PEG2000. Colloids Surf B. 2019;182:110337.
   PubMed Web of Science ®Google Scholar
• Dong D, Hsiao C-H, Giovanella BC, et al. Sustained delivery of a camptothecin prodrug–CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity. Int J Nanomed. 2019;14:3799.
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Xue A, Goodwin K, et al. Sustained release and improved bioavailability in mice after subcutaneous administration of griseofulvin as nano-and microcrystals. Int J Pharm. 2019;566:565–572.
   PubMedGoogle Scholar
• Liang P, Wu H, Zhang Z, et al. Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma. Int J Pharm. 2020;583:119375.
   PubMed Web of Science ®Google Scholar
• Tekko IA, Permana AD, Vora L, et al. Localised and sustained intradermal delivery of methotrexate using nanocrystal-loaded microneedle arrays: potential for enhanced treatment of psoriasis. Eur J Pharm Sci. 2020;152:105469.
   PubMed Web of Science ®Google Scholar
• Gautam N, McMillan JM, Kumar D, et al. Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir. Nat Commun. 2021;12(1):1–13.
   PubMed Web of Science ®Google Scholar
• Li Q, Chen F, Liu Y, et al. A novel albumin wrapped nanosuspension of meloxicam to improve inflammation-targeting effects. Int J Nanomed. 2018;13:4711.
   PubMed Web of Science ®Google Scholar
• McConnachie LA, Kinman LM, Koehn J, et al. Long-acting profile of 4 drugs in 1 anti-HIV nanosuspension in nonhuman primates for 5 weeks after a single subcutaneous injection. J Pharm Sci. 2018;107(7):1787–1790.
   PubMed Web of Science ®Google Scholar
• Han J, Zhou X, Fu J, et al. Annonaceous acetogenins nanosuspensions stabilized by poloxamer 188: preparation, properties and in vivo evaluation. J Drug Deliv Sci Technol. 2021;66:102676.
   Web of Science ®Google Scholar
• Gao Y, Vogus D, Zhao Z, et al. Injectable hyaluronic acid hydrogels encapsulating drug nanocrystals for long‐term treatment of inflammatory arthritis. Bioeng Transl. 2022;7(1):e10245.
   PubMed Web of Science ®Google Scholar
• Maudens P, Seemayer CA, Pfefferlé F, et al. Nanocrystals of a potent p38 MAPK inhibitor embedded in microparticles: therapeutic effects in inflammatory and mechanistic murine models of osteoarthritis. J Control Release. 2018;276:102–112.
   PubMed Web of Science ®Google Scholar
• Li H, Liu B, Ao H, et al. Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy. J Nanobiotechnology. 2020;18(1):1–11.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li H, Wang L, et al. Mucoadhesive nanocrystal-in-microspheres with high drug loading capacity for bioavailability enhancement of silybin. Colloids Surf B. 2021;198:111461.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao J, Guan J, et al. Exploration of nanocrystal technology for the preparation of lovastatin immediate and sustained release tablets. J Drug Deliv Sci Technol. 2019;50:107–112.
   Web of Science ®Google Scholar
• Kurakula M, El-Helw A, Sobahi TR, et al. Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy. Int J Nanomed. 2015;10:321.
   PubMed Web of Science ®Google Scholar
• Han S, Li X, Zhou C, et al. Further enhancement in intestinal absorption of paclitaxel by using transferrin-modified paclitaxel nanocrystals. ACS Appl Bio Mater. 2020;3(7):4684–4695.
   PubMedGoogle Scholar
• Augustine R, Ashkenazi DL, Arzi RS, et al. Nanoparticle-in-microparticle oral drug delivery system of a clinically relevant darunavir/ritonavir antiretroviral combination. Acta Biomater. 2018;74:344–359.
   PubMed Web of Science ®Google Scholar
• Li H, Li M, Fu J, et al. Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions. Drug Deliv. 2021;28(1):1226–1236.
   PubMed Web of Science ®Google Scholar
• Li J, Yang M, W-RJDD X, et al. Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin. Drug Des Dev Ther. 2018;12:3491.
   PubMed Web of Science ®Google Scholar
• Saindane NS, Pagar KP, Vavia PR. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization. AAPS PharmSciTech. 2013;14(1):189–199.
   PubMed Web of Science ®Google Scholar
• T-T F, Cong Z-Q, Zhao Y, et al. Fluticasone propionate nanosuspensions for sustained nebulization delivery: an in vitro and in vivo evaluation. Int J Pharm. 2019;572:118839.
   PubMedGoogle Scholar
• Rad RT, Dadashzadeh S, Vatanara A, et al. Tadalafil nanocomposites as a dry powder formulation for inhalation, a new strategy for pulmonary arterial hypertension treatment. Eur J Pharm Sci. 2019;133:275–286.
   PubMed Web of Science ®Google Scholar
• Hu X, Yang -F-F, Wei X-L, et al. Curcumin acetate nanocrystals for sustained pulmonary delivery: preparation, characterization and in vivo evaluation. J Biomed Nanotechnol. 2017;13(1):99–109.
   PubMed Web of Science ®Google Scholar
• Liu T, Han M, Tian F, et al. Budesonide nanocrystal-loaded hyaluronic acid microparticles for inhalation: in vitro and in vivo evaluation. Carbohydr Polym. 2018;181:1143–1152.
   PubMed Web of Science ®Google Scholar
• Donia M, Osman R, Awad GA, et al. Polypeptide and glycosaminoglycan polysaccharide as stabilizing polymers in nanocrystals for a safe ocular hypotensive effect. Int J Biol Macromol. 2020;162:1699–1710.
   PubMed Web of Science ®Google Scholar
• Permana AD, Utami RN, Layadi P, et al. Thermosensitive and mucoadhesive in situ ocular gel for effective local delivery and antifungal activity of itraconazole nanocrystal in the treatment of fungal keratitis. Int J Pharm. 2021;602:120623.
   PubMedGoogle Scholar
• Ali HS, York P, Ali AM, et al. Hydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet milling. J Control Release. 2011;149(2):175–181.
   PubMed Web of Science ®Google Scholar
• Atia NM, Hazzah HA, Gaafar PM, et al. Diosmin nanocrystal–loaded wafers for treatment of diabetic ulcer: in vitro and in vivo evaluation. J Pharm Sci. 2019;108(5):1857–1871.
   PubMed Web of Science ®Google Scholar
• Noh J-K, Naeem M, Cao J, et al. Herceptin-functionalized pure paclitaxel nanocrystals for enhanced delivery to HER2-positive breast cancer cells. Int J Pharm. 2016;513(1–2):543–553.
   PubMedGoogle Scholar
• Liu Y, Wang R, Hou J, et al. Paclitaxel/chitosan nanosupensions provide enhanced intravesical bladder cancer therapy with sustained and prolonged delivery of paclitaxel. ACS Appl Bio Mater. 2018;1(6):1992–2001.
   PubMedGoogle Scholar
• Liu G, Li S, Huang Y, et al. Incorporation of 10-hydroxycamptothecin nanocrystals into zein microspheres. Chem Eng Sci. 2016;155:405–414.
   Web of Science ®Google Scholar
• Dev A, Sood A, Choudhury SR, et al. Paclitaxel nanocrystalline assemblies as a potential transcatheter arterial chemoembolization (TACE) candidate for unresectable hepatocellular carcinoma. Mater Sci Eng C. 2020;107:110315.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang D, Lu S, et al. Pramipexole nanocrystals for transdermal permeation: characterization and its enhancement micro-mechanism. Eur J Pharm Sci. 2018;124:80–88.
   PubMed Web of Science ®Google Scholar
• Im SH, Jung HT, Ho MJ, et al. Montelukast nanocrystals for transdermal delivery with improved chemical stability. Pharmaceutics. 2019;12(1):18.
   PubMed Web of Science ®Google Scholar
• Li M, Azad M, Davé R, et al. Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective. Pharmaceutics. 2016;8(2):17.
   PubMed Web of Science ®Google Scholar
• DailyMed - INVEGA SUSTENNA- paliperidone palmitate injection]. [cited 2022 May 9]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1af14e42-951d-414d-8564-5d5fce138554
   Google Scholar
• Kim S, Solari H, Weiden PJ, et al. Paliperidone palmitate injection for the acute and maintenance treatment of schizophrenia in adults. Patient Prefer Adherence. 2012;6:533.
   PubMed Web of Science ®Google Scholar
• DailyMed - INVEGA TRINZA- paliperidone palmitate injection, suspension, extended release. [cited 2022 May 9]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c39e65d7-fa44-4e4c-8b12-a654d3ed0eae
   Google Scholar
• DailyMed - INVEGA HAFYERA- paliperidone palmitate injection, suspension, extended release. [cited 2022 May 9]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6cd61892-d2cb-434d-83ed-5c1b2c4e7a0b
   Google Scholar
• Jain R, Meyer J, Wehr A, et al. Size matters: the importance of particle size in a newly developed injectable formulation for the treatment of schizophrenia. CNS Spectr. 2020;25(3):323–330.
   PubMed Web of Science ®Google Scholar
• DailyMed - ARISTADA INITIO- aripiprazole lauroxil injection, suspension, extended release. [cited 2022 May 9]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b18fdfd9-31cd-4a2f-9f1c-ebc70d7a9403
   Google Scholar
• DailyMed - APRETUDE- cabotegravir kit. [cited 2022 May 9]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4338428e-43d4-4e02-ac9d-bd98e738a7da
   Google Scholar